Antineoplastic agents, 120. Pancratium littorale

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Pancratium littorale bulbs are a source of bioactive compounds.
• Phenanthridone alkaloids possess potential anticancer properties.

Purpose of the Study:

• To isolate and characterize new compounds from Pancratium littorale.
• To evaluate the antineoplastic activity of isolated compounds against specific cancer models.

Main Methods:

• Isolation and purification of compounds from plant extracts.
• In vitro and in vivo assays for cytotoxic and antitumor activity.
• X-ray crystallography and Nuclear Magnetic Resonance (NMR) spectroscopy for structural elucidation.

Main Results:

• Pancratistatin (4a) demonstrated significant life extension in murine P-388 lymphocytic leukemia and M-5076 ovary sarcoma models.
• Pancratistatin exhibited potent inhibition of P-388 cell growth in vitro.
• Structural determination of pancratistatin and its derivatives was achieved through X-ray and NMR analyses.
• Narciclasine (2c) and 7-deoxynarciclasine (2a) were identified as co-occurring antineoplastic constituents.

Conclusions:

• Pancratistatin is a novel and effective antineoplastic agent with potential for cancer therapy.
• The structural elucidation provides a basis for further synthetic and pharmacological studies.
• Pancratium littorale is a valuable source of potent anticancer natural products.